Value of Pyrazinamide for Composition of New Treatment Regimens for Multidrug-Resistant Mycobacterium Tuberculosis in China
BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-020-4758-9
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 7, 2020
Authors
Publisher
Springer Science and Business Media LLC